Great Point Partners as of Dec. 31, 2015
Portfolio Holdings for Great Point Partners
Great Point Partners holds 25 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Adamas Pharmaceuticals | 17.1 | $41M | 1.4M | 28.32 | |
| Five Prime Therapeutics | 9.9 | $24M | 570k | 41.50 | |
| Zogenix | 8.8 | $21M | 1.4M | 14.74 | |
| Vanda Pharmaceuticals (VNDA) | 8.2 | $20M | 2.1M | 9.31 | |
| Tetraphase Pharmaceuticals | 8.2 | $20M | 1.9M | 10.03 | |
| Connecture | 6.2 | $15M | 4.1M | 3.61 | |
| Alcobra | 5.3 | $13M | 2.0M | 6.28 | |
| Exelixis (EXEL) | 4.8 | $12M | 2.0M | 5.64 | |
| Synergy Pharmaceuticals | 3.7 | $8.8M | 1.5M | 5.67 | |
| Sunesis Pharmaceuticals | 3.1 | $7.4M | 8.3M | 0.90 | |
| Gw Pharmaceuticals Plc ads | 2.9 | $6.9M | 100k | 69.44 | |
| Paratek Pharmaceuticals | 2.8 | $6.7M | 356k | 18.97 | |
| Raptor Pharmaceutical | 2.8 | $6.7M | 1.3M | 5.20 | |
| Aurinia Pharmaceuticals (AUPH) | 2.6 | $6.2M | 2.5M | 2.51 | |
| Ocera Therapeutics | 2.6 | $6.1M | 2.0M | 3.12 | |
| Bovie Medical Corporation | 2.4 | $5.6M | 2.7M | 2.10 | |
| Vericel (VCEL) | 2.3 | $5.4M | 2.1M | 2.58 | |
| Aradigm | 1.7 | $4.0M | 1.0M | 3.97 | |
| Tenax Therapeutics | 1.5 | $3.6M | 1.1M | 3.28 | |
| Caladrius Biosciences | 1.0 | $2.4M | 2.2M | 1.08 | |
| Transition Therapeutics | 0.7 | $1.6M | 857k | 1.92 | |
| Flexion Therapeutics | 0.6 | $1.5M | 78k | 19.27 | |
| Cytokinetics (CYTK) | 0.5 | $1.1M | 107k | 10.46 | |
| MannKind Corporation | 0.3 | $729k | 503k | 1.45 | |
| Streamline Health Solutions (STRM) | 0.1 | $214k | 152k | 1.41 |
